Remy Durand serves as Executive at ALPINE IMMUNE SCIENCES, INC., where they oversee executive responsibilities. Since joining the company, Remy Durand has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 20, 2024 involved selling 102,192 shares valued at $0.
Remy Durand currently holds 31,200 shares of ALPINE IMMUNE SCIENCES, INC. (ALPN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Remy Durand has been a net neutral trader of ALPN stock. They have purchased $0 and sold $0 worth of shares.
Remy Durand's most recent insider trade was on May 20, 2024, when they sold 102,192 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 8, 2024 | ALPN | $47.6K | Option Exercise | 10,000 | $4.76 | Discretionary |
| May 8, 2024 | ALPN | $130.0K | Option Exercise | 9,845 | $13.20 | Discretionary |
| May 8, 2024 | ALPN | $50.6K | Option Exercise | 12,365 | $4.09 | Discretionary |
| May 8, 2024 | ALPN | $162.8K | Option Exercise | 25,000 | $6.51 | Discretionary |
| May 8, 2024 | ALPN | $123.0K | Option Exercise | 38,078 | $3.23 | Discretionary |
| Jan 4, 2024 | ALPN | $0 | Award | 31,200 | $N/A | Discretionary |